Fig. 1: Overview of the genomic analysis of Wilms tumor samples. | Communications Biology

Fig. 1: Overview of the genomic analysis of Wilms tumor samples.

From: Targeting TRIP13 in favorable histology Wilms tumor with nuclear export inhibitors synergizes with doxorubicin

Fig. 1

Co-mutation plot representing the clinicopathological information (top panel), loss of heterozygosity and copy number analyses (middle two panels), and mutations (bottom panel) in the matched WT cell lines, PDX-derived cell lines, patient tumors, and normal cell lines and tissues where applicable. Each column represents a particular sample.

Back to article page